Random question about exams....

[SUFC_Al]

Felt? I KNOW it went ok lol

I wrote 7 pages of A4 so it better have gone ok lol

okay sorry :thump:

ha ha although shouldn't you have wrote more than just "7 pages of A4" :hilarious:

 

[Cheltenham Shrimper]

okay sorry :thump:

ha ha although shouldn't you have wrote more than just "7 pages of A4" :hilarious:

Ha, you should become a comedian...

:minger:

 

[SUFC_Al]

Ha, you should become a comedian...

:minger:

I try my best :angel:

 

[Napster]

i've got a lovely one tomorrow - 2 hrs of pharmaceutical economics and policy.

the england game might be more enjoyable than revision!

oooh, interesting. are we talking health economics, selling to the NHS that kind of thing. easy.

 

[Pubey]

oooh, interesting. are we talking health economics, selling to the NHS that kind of thing. easy.

yeah i'm doing MSc International Health Policy (Health Economics)

pretty much it is about NHS financing, reimbursement, drug evaluation and application process yada yada yada


anyway my one this morning was shocking. the exam was 2 essays from 6 and i revised 3 topics from 8 and none of the topics came up. the exam was a biatch and im screwed!

 

[Napster]

yeah i'm doing MSc International Health Policy (Health Economics)

pretty much it is about NHS financing, reimbursement, drug evaluation and application process yada yada yada


anyway my one this morning was shocking. the exam was 2 essays from 6 and i revised 3 topics from 8 and none of the topics came up. the exam was a biatch and im screwed!

Oh dear.

I'm doing an event on how pharma companies can sell better to the NHS- big topic at the mo is PBC and to a lesser extent, PBR, but I'm sure you know that.

 

[Pubey]

yeah pbc is a really interesting topic actually and aligning motives and incentives for purchasers and providers/physicians is what i'm interested in, especially the equity implications. PBR is also a big area especially after the introduction of the new GP contract and it's exciting in that the NHS is one of the forefunners with this scheme.

 

[Pubey]

by the way do you work in pharma?

 

[Napster]

yeah pbc is a really interesting topic actually and aligning motives and incentives for purchasers and providers/physicians is what i'm interested in, especially the equity implications. PBR is also a big area especially after the introduction of the new GP contract and it's exciting in that the NHS is one of the forefunners with this scheme.

Politically and to a lesser extent, financially, I can see the reasons why the changes are being made - you get more bang for your buck letting GPs decide what drugs to buy and on an epidemiological level it makes sense as well, but on a personal level, the whole move to more primary care worries me - it's not thought through in terms of A&E realignment and cottage hospitals.

Still, at least the NHS is being looked at more closely.

 

[Napster]

by the way do you work in pharma?

Nope, I'm a conference director for an events organisation, but I've been dealing with pharma for last 3 years or so, so know a few names and what's going on and so on.

 

[Pubey]

Politically and to a lesser extent, financially, I can see the reasons why the changes are being made - you get more bang for your buck letting GPs decide what drugs to buy and on an epidemiological level it makes sense as well, but on a personal level, the whole move to more primary care worries me - it's not thought through in terms of A&E realignment and cottage hospitals.

Still, at least the NHS is being looked at more closely.

agreed....care pathways is a massive area and stumbling block for PBC and the equity and coverage implications are a worry too